Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma’s peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
89
Frequently Asked Questions
What is Market Cap of Ra Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ra Pharmaceuticals Inc market cap is N/A.
What is the 52-week high for Ra Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ra Pharmaceuticals Inc 52 week high is N/A as of September 26, 2025.
What is the 52-week low for Ra Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ra Pharmaceuticals Inc 52 week low is N/A as of September 26, 2025.
What is Ra Pharmaceuticals Inc stock price today?
Ra Pharmaceuticals Inc stock price today is $48.00.
What was Ra Pharmaceuticals Inc stock price yesterday?
Ra Pharmaceuticals Inc stock price yesterday was $48.01.
What is the PE ratio of Ra Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ra Pharmaceuticals Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Ra Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ra Pharmaceuticals Inc P/B ratio is None.
What is Ra Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Ra Pharmaceuticals Inc's EBITDA is -18.54.
What is the 50-day moving average of Ra Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ra Pharmaceuticals Inc 50-day moving average is N/A.
How many employess does Ra Pharmaceuticals Inc has?
